ロード中...
Repeated Favorable Responses to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in a Case of Advanced Lung Adenocarcinoma
The presence of epidermal growth factor receptor (EGFR) mutation is a prognostic and predictive marker for EGFR-tyrosine kinase inhibitor (TKI) therapy. However, inevitably, relapse occurs due to the development of acquired resistance, such as T790M mutation. We report a case of repeated responses t...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2013
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3617133/ https://ncbi.nlm.nih.gov/pubmed/23579627 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4046/trd.2013.74.3.129 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|